icotine patch preloading for smoking cessation: The Preloading Trial

Phase 4

Completed

• Conditions: Tobacco smoking; smoking cessation; nicotine addiction; Mental and Behavioural Disorders; Disorders due to use of tobacco

• Registration Number: ISRCTN33031001
• Lead Sponsor: niversity of Birmingham (UK)

Brief Summary

2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25052334 2018 results in: http://www.ncbi.nlm.nih.gov/pubmed/30079863 2018 results in: http://www.ncbi.nlm.nih.gov/pubmed/29899061 2018 analysis of pre-loading in: https://www.ncbi.nlm.nih.gov/pubmed/30066385 (added 18/12/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-04-27
• Study Completion: 2016-08-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1792

Inclusion Criteria

1. Smokers (defined as regular smokers of cigarettes, cigars, and tobacco cigarettes combined with marijuana)
2. Aged =18 years of age
3. Smokers who, in the judgement of the trial researcher, would be suitable for preloading
4. Seeking NHS support to stop smoking and willing to quit in 4 weeks
5. Able to understand and consent to, and willing to comply with, study procedures

Exclusion Criteria

1. Pregnant or breastfeeding
2. Extensive dermatitis/other skin disorder that precludes patch use
3. Acute coronary syndrome or stroke within the past three weeks
4. Active phaeocromocytoma
5. Uncontrolled hyperthyroidism

Study & Design

• Study Type: Interventional
• Study Design: Not specified